Monographie - Temocilline

Viimeisin päivitys :
03/05/2024

Temocilline

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Negaban

Belgia, Iso-Britannia, Luxemburg, Ranska

Viitteet : Temocilline

	Tyyppi	Julkaisu
2231	Lehti	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2275	Lehti	Craig Dyar S, Notari RE. Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers. Int J Pharm 1998 ; 173: 221-232.
2296	Laboratorio	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
3154	Lehti	Carryn S, Couwenbergh N, Tulkens PM Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients. J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
3255	Lehti	Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L. Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment Ann Pharm Fr 2011 ; 69, 6 : 296-301.
3385	Lehti	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3520	Laboratorio	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratorio	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3549	Laboratorio	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratorio	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratorio	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
4470	Lehti	Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. Continuous versus intermittent infusion of temocillin in intensive care unit patient. Critical care 2005 ; 9(Suppl 1) P37
4634	Lehti	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458

Mentions Légales